Generic Name for ATELVIA
Risedronate (as sodium) 35mg; delayed-release tabs.
Legal Classification:
Rx
Pharmacological Class for ATELVIA
Bisphosphonate.
Manufacturer of ATELVIA
Warner Chilcott Laboratories
|
Indications for ATELVIA
Treatment of postmenopausal osteoporosis.
Adult dose for ATELVIA
Swallow whole; take in the AM with a full glass (4 oz) plain (not mineral) water immediately after breakfast; take in upright position; do not lie down for at least 30 minutes afterwards. 35mg once weekly.
Children's dosing for ATELVIA
Not recommended.
Contraindications for ATELVIA
Esophagus abnormalities which delay esophageal emptying (eg, stricture, achalasia). Inability to stand or sit upright for at least 30 minutes. Hypocalcemia.
Warnings/Precautions for ATELVIA
Active upper GI disease; discontinue and reevaluate if signs/symptoms of esophageal reaction occur. Severe renal impairment (CrCl <30mL/min): not recommended. Correct preexisting hypocalcemia, other mineral or bone disturbances before starting. Ensure adequate Vit. D and calcium intake. Consider discontinuing therapy during invasive dental procedures (eg, tooth extraction, implants, surgery). History of bisphosphonate exposure: evaluate for atypical fractures if thigh/groin pain develops; consider withholding therapy until risk/benefit assessment. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers: not recommended.
Interactions for ATELVIA
Concomitant H2-blockers, PPIs, or other risedronate-containing products (eg, Actonel): not recommended. Calcium or magnesium-based supplements, antacids, laxatives, or iron preparations reduce absorption (separate dosing). Caution with aspirin, NSAIDs, other GI irritants. May interfere with bone-imaging agents.
Adverse Reactions for ATELVIA
GI upset, abdominal pain, influenza, musculoskeletal pain (may be severe), others; atypical femur fractures; rarely: dysphagia, esophagitis, gastric ulcer, jaw osteonecrosis; hypersensitivity.
How is ATELVIA supplied?
Tabs—4